Neurochemical and psychopharmacological approaches to cognitive enhancersNABESHIMA, Toshitaka; DE WIED, David; PEPEU, Giancarlo et al.Behavioural brain research. 1997, Vol 83, Num 1-2, issn 0166-4328, 252 p.Conference Proceedings

WHAT WE HAVE LEARNED FROM THE XALIPRODEN SANOFI-AVENTIS TRIALSDOUILLET, P; ORGOGOZO, J.-M.The Journal of nutrition, health & aging. 2009, Vol 13, Num 4, pp 365-366, issn 1279-7707, 2 p.Article

Piracetam and other structurally related nootropicsGOULIAEV, A. H; SENNING, A.Brain research reviews. 1994, Vol 19, Num 2, pp 180-222, issn 0165-0173Article

Behavioural effects of Visnea mocanera extract : psychostimulant and anxiogenic propertiesHERNANDEZ-PEREZ, M; SANCHEZ MATEO, C. C; DARIAS, V et al.PTR. Phytotherapy research. 1995, Vol 9, Num 4, pp 299-305, issn 0951-418XArticle

Simultaneous determination of nefiracetam and its metabolites by high-performance liquid chromatographyFUJIMAKI, Y; SUDO, K; HAKUSUI, H et al.Journal of chromatography. Biomedical applications. 1992, Vol 575, Num 2, pp 261-268, issn 0378-4347Article

Long-term memory loss and the effects of tianeptine in young and aged miceLEBRUN, C; JAFFARD, R.European psychiatry. 1993, Vol 8, pp 81s-88s, issn 0924-9338, SUP2Conference Paper

Determination of oxiracetam in human serum and urine by high-performance liquid chromatographyVISCONTI, M; SPALLUTO, R; CROLLA, T et al.Journal of chromatography. 1987, Vol 416, Num 2, pp 433-438, issn 0021-9673Article

Spectrophotometric determination of pyrithioxine in pharmaceutical formulationsSASTRY, C. S. P; MURALI KRISHNA, D.Analytical letters. 1995, Vol 28, Num 7, pp 1197-1207, issn 0003-2719Article

Effects of putative cognition enhancers on the NMDA receptor by [³H]MK801 bindingHAMELIN, S. M; LEHMANN, J. C.European journal of pharmacology. 1995, Vol 281, Num 3, pp R11-R13, issn 0014-2999Article

Probable psychosis associated with levetiracetam: A case reportAGGARWAL, Ashish; SHARMA, Dinesh D; SHARMA, Ravi C et al.Progress in neuro-psychopharmacology & biological psychiatry. 2011, Vol 35, Num 1, pp 274-275, issn 0278-5846, 2 p.Article

Delayed cardiotoxicity in chronic lithium poisoning : Discrepancy between serum lithium concentrations and clinical statusWARING, William Stephen.Basic & clinical pharmacology & toxicology (Print). 2007, Vol 100, Num 5, pp 353-355, issn 1742-7835, 3 p.Article

Piracétam : Risque hémorragique = Piracetam: hemorrhage riskLa Revue Prescrire. 2005, Vol 25, Num 257, issn 0247-7750, p. 23Article

Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a reviewZS.-NAGY, I.Archives of gerontology and geriatrics. 1990, Vol 11, Num 3, pp 177-186, issn 0167-4943, 10 p.Article

Emploi d'un nouveau psychotrope, le bémitil dans le traitement des troubles asthéniques (étude clinique et pharmacologique)ALEKSANDROVSKIJ, YU. A; BOBKOV, YU. G; NEZNAMOV, G. G et al.Žurnal nevropatologii i psihiatrii im. S.S. Korsakova. 1988, Vol 88, Num 3, pp 109-115, issn 0044-4588Article

Levetiracetam as adjunctive therapy for refractory anxiety disordersKINRYS, Gustavo; WORTHINGTON, John J; WYGANT, Lisa et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 7, pp 1010-1013, issn 0160-6689, 4 p.Article

A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionalityBROMIDGE, S. M; BROWN, F; CASSIDY, F et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 791-796Book Chapter

Cognition enhancers : from animals to man, Paris, October 12-14 th, 1988PORSOLT, R. D.Pharmacopsychiatry. 1990, Vol 23, issn 0176-3679, 73 p., suppl. 2Conference Proceedings

Does AAMI constitue a real disease entity ? a placebo-controlled double-blind study with sabeluzole (R58 735) in a patinet population with real memory problemTRITSMANS, L; CLINCKE, G; PEELMANS, B et al.Drug development research. 1990, Vol 20, Num 4, pp 473-482, issn 0272-4391, 10 p.Article

Behavioral screening for cognition enhancers : from indiscriminate to valid testing. ISARTER, M; HAGAN, J; DUDCHENKO, P et al.Psychopharmacologia. 1992, Vol 107, Num 2-3, pp 144-159, issn 0033-3158Article

An hypothesis on the role of glucose in the mechanism of action of cognitive enhancersWENK, G. L.Psychopharmacologia. 1989, Vol 99, Num 4, pp 431-438, issn 0033-3158Article

Mutagenicity study of the new cognition-enhancing agent nefiracetamSHIMADA, H; HATTORI, C; TANAKA, N et al.Arzneimittel-Forschung. 1994, Vol 44, Num 2A, pp 251-253, issn 0004-4172Article

Frequency of the adverse effects of lithiumPrescrire international (Paris). 2014, Vol 23, Num 147, pp 68-69, issn 1167-7422, 2 p.Article

Lithium in the Treatment of Major Depressive DisorderBSCHOR, Tom.Drugs (Basel). 2014, Vol 74, Num 8, pp 855-862, issn 0012-6667, 8 p.Article

Total and regional brain volume reductions due to the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): A voxel-based morphometric studyIKEDA, Yuko; KAMEYAMA, Masaki; AMANUMA, Makoto et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 1, pp 244-246, issn 0278-5846, 3 p.Article

Lithium toxicity presenting as catatonia in an adolescent girlDESARKAR, Pushpal; DAS, Anindya; DAS, Basudeb et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 4, pp 410-412, issn 0271-0749, 3 p.Article